Company: CERO
Filing Date: 2025-05-07
Form Type: DEF 14A
Source: 0001213900-25-040263
Chunk: 137

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-07
Form: DEF 14A
Chunk 137
---
 will reimburse such brokerage houses, custodians, nominees and fiduciaries for reasonable out -of-pocketexpenses incurred in connection therewith. The Company has engaged Okapi to assist the Company with the solicitation of proxies for the Annual Meeting. The Company expects to pay Okapi $10,000, plus expenses, for its services. 80 ANNUAL REPORT The Company will provide without charge to each person to whom a copy of the proxy statement is delivered, upon the written or oral request of any such persons, additional copies of the Company’s Annual Report as filed with the SEC. Requests for such copies should be addressed to: CERo Therapeutics Holdings, Inc., 201 Haskins Way, Suite 230, South San Francisco, CA 94080, Attention: Secretary. OTHER MATTERS The Annual Meeting is called for the purposes set forth in herein. The Board does not know of any other matters to be considered by the stockholders at the Annual Meeting, other than the matters described in herein. However, the enclosed proxy confers discretionary authority on the persons named in the proxy card with respect to matters that may properly come before the Annual Meeting and that are not known to the Board at the date this proxy statement was printed. It is the intention of the persons named in the proxy card to vote in accordance with their best judgment on any such matter. WHERE YOU CAN FIND ADDITIONAL INFORMATION The Company files reports, proxy statements and other information with the SEC as required by the Exchange Act. You can review CERo’s electronically -filedreports, proxy and information statements on the SEC’s web site at www.sec.govor on CERo’s web site at www.cero.bio. Information included on the Company’s website is not a part of this proxy statement. You should rely only on the information contained in this proxy statement or on information to which the Company has referred you. The Company has not authorized anyone else to provide you with any information. You should not assume that the information contained in this document is accurate as of any date other than that date, and the provision of this document to stockholders at any time after that date does not create an implication to the contrary. This proxy statement does not constitute a solicitation of a proxy in any jurisdiction where, or to or from any person to whom, it is unlawful to make such proxy solicitations in such jurisdiction. If you have more questions about this proxy statement or how to submit your proxy, or if you need additional copies of this proxy statement or the enclosed